PT - JOURNAL ARTICLE AU - Zhang, Lanyu AU - Young, Juan I. AU - Gomez, Lissette AU - Silva, Tiago C. AU - Schmidt, Michael A. AU - Cai, Jesse AU - Chen, Xi AU - Martin, Eden R. AU - Wang, Lily TI - Sex-specific DNA methylation changes in Alzheimer’s disease pathology AID - 10.1101/2021.03.01.21252029 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.01.21252029 4099 - http://medrxiv.org/content/early/2021/03/02/2021.03.01.21252029.short 4100 - http://medrxiv.org/content/early/2021/03/02/2021.03.01.21252029.full AB - Sex is an important factor that contributes to the clinical and biological heterogeneities in Alzheimer’s disease (AD), but the regulatory mechanisms underlying sex disparity in AD are still not well understood. DNA methylation is an important epigenetic modification that regulates gene transcription and is known to be involved in AD. We performed the first large-scale sex-specific meta-analysis of DNA methylation changes in AD, by re-analyzing four recent epigenome-wide association studies totaling more than 1000 postmortem prefrontal cortex brain samples using a uniform analytical pipeline. For each cohort we employed two complementary analytical strategies, a sex-stratified analysis that examined methylation-Braak stage associations in male and female samples separately, and a sex-by-Braak stage interaction analysis that compared the magnitude of these associations between different sexes. Our analysis uncovered 14 novel CpGs, mapped to genes such as TMEM39A and TNXB that are associated with AD in a sex-specific manner. TMEM39A is known to be involved in inflammation, dysregulated type I interferon responses, and other immune processes. TNXB encodes tenascin proteins, which are extracellular matrix glycoproteins demonstrated to modulate synaptic plasticity in the brain. Moreover, for many previously implicated AD genes, such as MBP and AZU1, our analysis provided the new insights that they were predominately driven by effects in only one sex. These sex-specific DNA methylation changes were enriched in divergent biological processes such as integrin activation in females and complement activation in males. Importantly, a number of drugs commonly prescribed for AD patients also targeted these genes with sex-specific DNA methylation changes. Our study implicated multiple new loci and biological processes that affected AD in a sex-specific manner and highlighted the importance of sex-specific treatment regimens for AD patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by US National Institutes of Health grants R21AG060459 (L.W), R01AG061127 (L.W.), R01AG062634 (E.R.M, L.W.), and 1R01AG060472 (E.R.M).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for ROSMAP dataset was obtained through Synapse. The ROSMAP study data were provided by the Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. The original Religious Orders Study and Rush Memory and Aging Project were approved by Institutional Review Board (IRB) of Rush University Medical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll datasets analyzed in this study are publicly available as described in Supplementary Table 1. The Mt. Sinai, London, Gasparoni and ROSMAP datasets can be accessed from GEO (accessions GSE80970, GSE59685, GSE66351) and Synapse (DOI:10.7303/syn3157275). The scripts for the analysis performed in this study can be accessed at https://github.com/TransBioInfoLab/ad-meta-analysis-by-sex https://github.com/TransBioInfoLab/ad-meta-analysis-by-sex